Previous Close | 2.5400 |
Open | 2.5600 |
Bid | 2.3100 x 2900 |
Ask | 2.7900 x 1300 |
Day's Range | 2.2750 - 2.6189 |
52 Week Range | 0.9200 - 7.8000 |
Volume | |
Avg. Volume | 753,504 |
Market Cap | 160.307M |
Beta (5Y Monthly) | 1.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.8900 |
Earnings Date | Nov 09, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for OMER
Omeros Corporation (NASDAQ:OMER) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon, and welcome to today’s earnings call for Omeros Corporation. At this time, all participants are in a listen-only mode. After the company’s remarks, we will conduct a question-and-answer session. And please be advised that this call is being recorded at the […]
SEATTLE, November 09, 2023--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2023, which in